BPC-157 is an experimental peptide investigated primarily in preclinical research. It is not an established routine human medicine with a generally recognized approved indication.

The Sixpex listing does not provide a verified numerical strength, dosage form, formulation, or package quantity. These specifications should be confirmed from current product documentation.

FDA has identified limited safety information and potential concerns involving immunogenicity and peptide-related impurities for BPC-157 preparations.